Condition: Mitral Valve Insufficiency · Sponsor: Half Moon Medical
The study is a prospective, multi-center, single-arm, non-randomized, Early Feasibility Study (EFS) to evaluate the safety and performance of the Half Moon TMVr System in patients with severe, symptomatic mitral regurgitation, who are at high risk for conventional mitral valve surgery.
This description comes directly from the study's public registry record.
Craig Straley · 4153109197 · craigstraley.halfmoon@gmail.com
Romil Rambhia · rrambhia@thefoundry.com
Always discuss trial participation with your own doctor first.
| Columbia University Medical Center/NewYork Presbyterian Hospital | New York, New York, United States | Recruiting |
| Montefiore Medical Center | The Bronx, New York, United States | Recruiting |
| University Hospitals Cleveland Medical Center | Cleveland, Ohio, United States | Recruiting |
| Oregon Health & Science University | Portland, Oregon, United States | Recruiting |
| UPMC Heart & Vascular Institute | Harrisburg, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04343313